Sanjurjo-Sáez M - Search Results

1

Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease.

Hoyo-Muñoz A, Collado-Borrell R, Escudero-Vilaplana V, Bastos-Oreiro M, Herranz-Alonso A, Sanjurjo-Sáez M. Hoyo-Muñoz A, et al. J Clin Pharm Ther. 2022 Apr;47(4):548-551. doi: 10.1111/jcpt.13513. Epub 2021 Sep 12. J Clin Pharm Ther. 2022. PMID: 34514634

2

[Internal invoicing of end products manufactured by a hospital Pharmacy Department].

Caro González L, Herranz Alonso A, Pernia S, Mur Mur A, Sánchez Fresneda M, Sarobe González C, Martín Barnero M, Sanjurjo Sáez M. Caro González L, et al. Farm Hosp. 2002 Sep-Oct;26(5):266-274. Farm Hosp. 2002. PMID: 12595938 Spanish.

3

[Pharmacy].

Herranz Alonso A, Caro González L, Castillo Romera I, Sanjurjo Sáez M, Sarobe González C. Herranz Alonso A, et al. Med Clin (Barc). 2005 Mar 1;124 Suppl 1:46. doi: 10.1157/13072649. Med Clin (Barc). 2005. PMID: 15771848 Spanish.

4

[Smart infusion pumps: lights and shadows of an emerging technology].

Manrique-Rodríguez S, Fernández-Llamazares CM, Herranz-Alonso A, Sanjurjo-Sáez M. Manrique-Rodríguez S, et al. Med Clin (Barc). 2011 Sep 24;137(8):361-5. doi: 10.1016/j.medcli.2010.01.016. Epub 2010 Mar 7. Med Clin (Barc). 2011. PMID: 20211476 Spanish. No abstract available.

5

Prevalence of medication administration errors in two medical units with automated prescription and dispensing.

Rodriguez-Gonzalez CG, Herranz-Alonso A, Martin-Barbero ML, Duran-Garcia E, Durango-Limarquez MI, Hernández-Sampelayo P, Sanjurjo-Saez M. Rodriguez-Gonzalez CG, et al. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):72-8. doi: 10.1136/amiajnl-2011-000332. Epub 2011 Sep 2. J Am Med Inform Assoc. 2012. PMID: 21890872 Free PMC article.

6

Validation of a method for recording pharmaceutical interventions.

Fernández-Llamazares CM, Manrique-Rodríguez S, Pérez-Sanz C, Durán-García ME, Sanjurjo-Sáez M, Calleja-Hernández MA. Fernández-Llamazares CM, et al. J Clin Pharm Ther. 2012 Aug;37(4):459-63. doi: 10.1111/j.1365-2710.2011.01328.x. Epub 2011 Dec 28. J Clin Pharm Ther. 2012. PMID: 22211951

7

Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis.

Escudero-Vilaplana V, Ramírez-Herraiz E, Trovato-López N, Alañón-Plaza E, Bellini MJ, Herranz-Alonso A, Bellón-Cano JM, Morell-Baladrón A, Sanjurjo-Sáez M. Escudero-Vilaplana V, et al. J Pharm Pharm Sci. 2012;15(3):355-60. doi: 10.18433/j33w30. J Pharm Pharm Sci. 2012. PMID: 22974785 Free article.

8

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis.

Escudero-Vilaplana V, Martínez-Nieto C, López-Gómez JM, Vega-Martínez A, Bellón-Cano JM, Sanjurjo-Sáez M. Escudero-Vilaplana V, et al. Int J Clin Pharm. 2013 Jun;35(3):463-8. doi: 10.1007/s11096-013-9774-z. Epub 2013 Apr 18. Int J Clin Pharm. 2013. PMID: 23595914

9

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice.

Ramírez-Herráiz E, Escudero-Vilaplana V, Alañón-Plaza E, Trovato-López N, Herranz-Alonso A, Morell-Baladrón A, Sanjurjo-Sáez M. Ramírez-Herráiz E, et al. Clin Exp Rheumatol. 2013 Jul-Aug;31(4):559-65. Epub 2013 May 27. Clin Exp Rheumatol. 2013. PMID: 23710583

10

The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.

Marquínez-Alonso I, Escudero-Vilaplana V, Pernía S, Beléndez Bieler C, Fernández-Llamazares CM, Sanjurjo-Sáez M. Marquínez-Alonso I, et al. J Clin Pharm Ther. 2014 Aug;39(4):376-82. doi: 10.1111/jcpt.12156. Epub 2014 Apr 4. J Clin Pharm Ther. 2014. PMID: 24702274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page